iBio (IBIO) Total Current Liabilities (2011 - 2026)

iBio (IBIO) has 16 years of Total Current Liabilities data on file, last reported at $6.5 million in Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 20.51% year-over-year to $6.5 million in Q1 2026; TTM through Mar 2026 was $6.5 million, a 20.51% increase from a year earlier, with the FY2025 full-year figure at $6.1 million, up 59.01% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $6.5 million, up from $5.9 million in the prior quarter.
• Over the last five years, Total Current Liabilities for IBIO reached as high as $32.2 million in Q3 2022 and fell as low as $3.5 million in Q3 2024.
• Historically, Total Current Liabilities has averaged $14.6 million across 5 years, with a median of $8.3 million in 2022.
• Across the five-year window, Total Current Liabilities jumped 358.03% in 2022 and slumped 83.25% in 2024, its largest moves.
• Year by year, Total Current Liabilities stood at $27.8 million in 2022, then declined by 22.4% to $21.6 million in 2023, then slumped by 78.15% to $4.7 million in 2024, then increased by 25.31% to $5.9 million in 2025, then advanced by 10.22% to $6.5 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $6.5 million in Q1 2026, $5.9 million in Q4 2025, and $6.0 million in Q3 2025.